Results 31 to 40 of about 32,366 (248)

Pulmonary involvement in brucellosis: A case report and literature review

Clinical Case Reports, 2021
Although pulmonary involvement is rare in brucellosis it should be considered as a causative agent in patients with prolonged fever and arthritis. Also, it should be presented with manifestations resembling systemic juvenile idiopathic arthritis.
Maryam Abdollahi, Vadood Javadi, Reza Shiari, Khosro Rahmani   +3 more
doaj   +1 more source

An exploration of parents’ preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment [PDF]

, 2014
Background: An increased awareness of patients’ and parents’ care preferences regarding foot care is desirable from a clinical perspective as such information may be utilised to optimise care delivery.
A Bernatsky, A Gafni, A Tong, AC Barron, AE Williams, AM Cahill, Arthritis and Musculoskeletal Alliance (ARMA), D McFadden, DE Feldman, Debbie E Turner, DJ Street, E Lancsar, E Lancsar, E McIntosh, F San Miguel, G Hendry, G Hendry, G Spraul, GJ Hendry, GJ Hendry, Gordon J Hendry, H Holman, HF Burnett, J Cairns, J Coast, J Ferrari, J Ratcliffe, J Ratcliffe, J Thornton, James Woodburn, Janet Gardner-Medwin, JH Barlow, JR De Shazo, JR Kirwan, K Davies, KT April, L Burgess, LJ Mangham, M Andre, M Bech, M Dekker, M Powell, M Ryan, M Ryan, M Ryan, M Ryan, MT King, Paula K Lorgelly, R McCarney, R Viney, RN Sylvester, S Bryan, T Beukelman, T Heiberg, T Kjaer, US Skjoldborg, W Gidman   +56 more
core   +3 more sources

CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN

Вопросы современной педиатрии, 2014
The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in ...
Ye. I. Alekseeva, R. V. Denisova
doaj   +1 more source

Validity of a three-variable juvenile arthritis disease activity score in children with new-onset juvenile idiopathic arthritis [PDF]

, 2012
<p>Objectives To investigate the validity and feasibility of the Juvenile Arthritis Disease Activity Score (JADAS) in the routine clinical setting for all juvenile idiopathic arthritis (JIA) disease categories and explore whether exclusion of the ...
Adib, Aletaha, Bazso, Beresford, Consolaro, Eileen M Baildam, Flora Mcerlane, Fuchs, Fuchs, Helen E Foster, Hyrich, Janet Gardner-Medwin, Joyce E Davidson, Kimme L Hyrich, Leeb, Lucy R Wedderburn, Magni-Manzoni, Mark Lunt, Michael W Beresford, Nordal, Nordal, Nugent, Petty, Petty, Ringold, S E Alice Chieng, Symmons, Wendy Thomson   +27 more
core   +2 more sources

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis [PDF]

Frontiers in Pharmacology, 2016
Systemic juvenile idiopathic arthritis (sJIA) is the form of childhood arthritis whose treatment is most challenging. The demonstration of the prominent involvement of interleukin (IL)-1 in disease pathogenesis has provided the rationale for the treatment with biologic medications that antagonize this cytokine.
Giancane, Gabriella, Minoia, Francesca, Davì, Sergio, Bracciolini, Giulia, Consolaro, Alessandro, Ravelli, Angelo   +5 more
openaire   +4 more sources

Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

Pediatric Rheumatology Online Journal, 2020
For reasons poorly understood, and despite the availability of biological medications blocking IL-1 and IL-6 that have markedly improved overall disease control, children with Systemic Juvenile Idiopathic Arthritis (SJIA) are now increasingly diagnosed ...
Scott W. Canna, Grant S. Schulert, Adriana de Jesus, Alex Pickering, Hermine Brunner, Massimo Gadina, Stewart Levine, Raphaela Goldbach-Mansky, Jonathan Boutelle, Rashmi Sinha, Fabrizio DeBenedetti, Alexei Grom, on behalf of the NextGen 2019 Participants   +12 more
doaj   +1 more source

The effectiveness of a multidisciplinary foot care program for children and adolescents with juvenile idiopathic arthritis: an exploratory trial [PDF]

, 2013
Objectives: To evaluate the effectiveness of multidisciplinary foot-care, and to evaluate the methodological considerations of a trial of multidisciplinary care in juvenile idiopathic arthritis. Design: Exploratory randomised controlled trial.
Brandon, Mhairi, Friel, Lorraine, Gardner-Medwin, Janet, Hendry, Gordon, Lorgelly, Paula K., Sturrock, Roger D., Turner, Deborah, Watt, Gordon, Woodburn, James   +8 more
core   +1 more source

Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease

Swiss Medical Weekly, 2012
Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still’s disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA).
Rolando Cimaz, Annette Von Scheven, Michael Hofer   +2 more
doaj   +1 more source

Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study [PDF]

, 2005
Juvenile rheumatoid arthritis (JRA) comprises a group of chronic systemic inflammatory disorders that primarily affect joints and can cause long-term disability.
Bukulmez, H, Colbert, RA, Elston, RC, Fife, M, Glass, DN, Olson, JM, Thompson, SD, Tsoras, M, Twine, NA, Woo, P   +9 more
core   +2 more sources

Clinical Case of Tocilizumab Use in a Patient with Systemic Juvenile Idiopathic Arthritis

Педиатрическая фармакология, 2016
The article presents a case of using genetically engineered biopharmaceutical tocilizumab in a child with systemic juvenile idiopathic arthritis. On the initial stage, the treatment was characterized by resistance to high doses of glucocorticoids and ...
Y. M. Spivakovskiy, Y. V. Chernenkov, A. Y. Spivakovskaya, O. V. Skupova, E. N. Shulgina   +4 more
doaj   +1 more source